Abstract:Background/Aims: Tolerance of T lymphocytes at the feto-maternal interface is necessary to sustain normal pregnancy. The present investigation aimed to observe the regulatory effects on T lymphocytes by human trophoblasts and to explore possible effector molecules. Methods: Conditioned media was made by trophoblast culture or villous explant culture for T lymphocyte proliferation and proteomic analysis. Lymphocyte proliferation was tested by thymidine incorporation. Messenger RNA for indoleamine 2,3-dioxygenase (IDO) was detected by RT-PCR and tryptophan was assayed. The protein profile of conditioned media was assessed with shotgun mass-spectrometry and the identified proteins were bioinformatically analyzed. Human chorionic gonadotropin (HCG), human chorionic somatomammotropin (HCS), interleukin (IL)-2, 4, 10 and tumor necrosis factor (TNF)-alpha were assayed with radioimmunoassay (RIA). Results: T Lymphocyte proliferation was inhibited by conditioned medium in a dose-dependant manner. Inhibition of IDO during previous conditioning or addition of tryptophan to the conditioned medium partly restored T lymphocyte proliferation. mRNA for IDO was expressed in trophoblasts and chorionic villi. The concentrations of tryptophan were 19.01 and 3.79 mu mol/L in unconditioned and conditioned media respectively. By proteomic procedures, 548 proteins were found in placenta-conditioned medium. Among these proteins were some proteins inhibiting T lymphocytes including HCG, HCS, AFP, pregnancy-specific beta 1-glycoprotein (SP1), glycodelin, transforming growth factor beta 2, thrombospondin-1, pigment epithelium-derived factor (PEDF), galectin-1, and macrophage migration inhibitory factor. HCG and HCS were also detected with RIA, however, no interleukins were detected in conditioned media with RIA or proteomic analysis. Conclusions: Trophoblasts inhibit T lymphocyte through IDO-mediated tryptophan depletion and placenta-derived immunoregulatory factors. Immunological tolerance at maternal-fetal interface represents a synergistic effect of these substances and a complex mechanism involving endocrine and immune networks. Copyright (C) 2008 S. Karger AG, Basel.

Study on Expression of Survivin Protein in Trophoblast Cells of Placenta of Postdate Labor

Expression of Survivin Protein and Its Relation with the Expression of Bcl-2 and Bax in the Trophoblasts of Human Normal Placenta

A Study on the Expression of Survivin Gene in Human Gastric Cancer

Expressions of survivin protein and survivin mRNA in placenta with pre-eclampsia

Reduced expression of survivin, the inhibitor of apoptosis protein correlates with severity of preeclampsia

Role of Survivin and MMP-9 in Regulating the Placental Development

The expressions of survivin and livin in placenta of pre-eclampsia and its significance

The Effect of Trophoblasts on T Lymphocytes: Possible Regulatory Effector Molecules - A Proteomic Analysis

Increased Expression of Fatty Acid Binding Protein 4 in Preeclamptic Placenta and Its Relevance to Preeclampsia.

The Influence of Mifepristone on the Expression of Trophinin,tastin and Bystin in Trophoblastic Cells in Human Placenta

The Research of the Expression of Stress-induced Caspase-3 and Livin in Early Preganant Placental Tissues

Expression of Survivin in the Normal Early Gestation Villi and Gestational Trophoblastic Diseases

Declined placental PLAC1 expression is involved in preeclampsia.

Research on the Expression of HOXA10 in Placental Villi During the Onset of Labor

Expression of Livin in gestational trophoblastic tumor and it's significance

Trophoblast type-specific expression of senescence markers in the human placenta

Expressions and significance of p-p38, caspase-3 and caspase-8 in placenta of patients with preeclampsia

Study on the expressions of PHD and HIF in placentas from normal pregnant women and patients with preeclampsia.

Expression of apoptotic gene in placenta tissue of hypertensive disorder complicating pregnancy

Expression of Survivin Gene among Human Normal Endometrium, Atypical Hyperplasia of Endometrium and Endometrial Carcinoma

[Expression of Survivin in Different Stages of Carcinogenesis and Progression of Breast Cancer].